Patent · US Active

Combination therapies for treatment of spinal muscular atrophy

US9895358B2 · kind B2 · utility

9Cited by

7References

5Claims

0Family size

Assignee

INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION · US

Inventors

Elliot J. Androphy · Natick, US
Kevin Hodgetts · Killingworth, US
Alyssa Nicole Calder · Cambridge, US

Key dates

Filing date	Feb 23, 2017
Grant date	Feb 20, 2018
Priority date	—
Expiry date	Feb 23, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for treatment of spinal muscular atrophy (SMA). In certain embodiments, compounds are provided that increase full-length survival of motor neuron (SMN) protein production by an SMN2 gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.